Future Considerations of Bispecific Antibody Therapy
Posted by
HealthTree
Last updated and reviewed on: October 17, 2025
The rapid research being done in the myeloma treatment field means that what we know about current therapies can continue to evolve. With bispecifics being so relatively new as a myeloma treatment, we are certain to see changes as it evolves.
The following sections will detail information like:
What role can bispecific antibody therapy play in eliminating geographic and other medical disparities?
How is real world data affecting how bispecifics are administered?
